William Blair Comments on Cott’s Q3 Earnings (TSE:PRM)

Cott Corp. (TSE:PRM) – William Blair issued their Q3 2024 EPS estimates for shares of Cott in a note issued to investors on Tuesday, November 5th. William Blair analyst J. Andersen expects that the company will earn $0.36 per share for the quarter. William Blair currently has a “Strong-Buy” rating on the stock. William Blair also issued estimates for Cott’s Q4 2024 earnings at $0.25 EPS and FY2025 earnings at $1.23 EPS.

Separately, Raymond James cut shares of Cott from a “moderate buy” rating to a “hold” rating in a report on Wednesday, October 2nd.

Cott Stock Down 1.7 %

Shares of PRM stock opened at C$13.17 on Friday. Cott has a 52-week low of C$13.17 and a 52-week high of C$14.97.

Cott (TSE:PRM) last issued its earnings results on Thursday, August 8th. The company reported C$0.30 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of C$0.32 by C($0.02). The firm had revenue of C$663.59 million for the quarter, compared to the consensus estimate of C$658.00 million.

Cott Dividend Announcement

The business also recently declared a None dividend, which will be paid on Thursday, November 21st. Investors of record on Tuesday, November 5th will be paid a $1.109 dividend. The ex-dividend date is Tuesday, November 5th.

About Cott

Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.